Cancer is a Preventable Disease that Requires Major Lifestyle Changes

被引:1353
作者
Anand, Preetha [1 ]
Kunnumakara, Ajaikumar B. [1 ]
Sundaram, Chitra [1 ]
Harikumar, Kuzhuvelil B. [1 ]
Tharakan, Sheeja T. [1 ]
Lai, Oiki S. [1 ]
Sung, Bokyung [1 ]
Aggarwal, Bharat B. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA
关键词
cancer; environmental risk factors; genetic risk factors; prevention;
D O I
10.1007/s11095-008-9661-9
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This year, more than 1 million Americans and more than 10 million people worldwide are expected to be diagnosed with cancer, a disease commonly believed to be preventable. Only 5-10% of all cancer cases can be attributed to genetic defects, whereas the remaining 90-95% have their roots in the environment and lifestyle. The lifestyle factors include cigarette smoking, diet (fried foods, red meat), alcohol, sun exposure, environmental pollutants, infections, stress, obesity, and physical inactivity. The evidence indicates that of all cancer-related deaths, almost 25-30% are due to tobacco, as many as 30-35% are linked to diet, about 15-20% are due to infections, and the remaining percentage are due to other factors like radiation, stress, physical activity, environmental pollutants etc. Therefore, cancer prevention requires smoking cessation, increased ingestion of fruits and vegetables, moderate use of alcohol, caloric restriction, exercise, avoidance of direct exposure to sunlight, minimal meat consumption, use of whole grains, use of vaccinations, and regular check-ups. In this review, we present evidence that inflammation is the link between the agents/factors that cause cancer and the agents that prevent it. In addition, we provide evidence that cancer is a preventable disease that requires major lifestyle changes.
引用
收藏
页码:2097 / 2116
页数:20
相关论文
共 124 条
  • [1] Agarwal R, 2006, ANTICANCER RES, V26, P4457
  • [2] Molecular targets of dietary agents for prevention and therapy of cancer
    Aggarwal, BB
    Shishodia, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 71 (10) : 1397 - 1421
  • [3] Nuclear factor-κ-B:: The enemy within
    Aggarwal, BB
    [J]. CANCER CELL, 2004, 6 (03) : 203 - 208
  • [4] γ-tocotrienol inhibits nuclear factor-κB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and Potentiation of apoptosis
    Ahn, Kwang Seok
    Sethi, Gautam
    Krishnan, Koyamangalath
    Aggarwal, Bharat B.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (01) : 809 - 820
  • [5] ALBANES D, 1987, CANCER RES, V47, P1987
  • [6] INFLUENCE OF ANETHOLE TREATMENT ON THE TUMOR-INDUCED BY EHRLICH ASCITES-CARCINOMA CELLS IN PAW OF SWISS ALBINO MICE
    ALHARBI, MM
    QURESHI, S
    RAZA, M
    AHMED, MM
    GIANGRECO, AB
    SHAH, AH
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 1995, 4 (04) : 307 - 318
  • [7] ANAND P, 2008, CANC LETT IN PRESS
  • [8] Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα:: correlation with induction of cyclooxygenase-2
    Anto, RJ
    Mukhopadhyay, A
    Shishodia, S
    Gairola, CG
    Aggarwal, BB
    [J]. CARCINOGENESIS, 2002, 23 (09) : 1511 - 1518
  • [9] The multitude and diversity of environmental carcinogens
    Belpomme, D.
    Irigaray, P.
    Hardell, L.
    Clapp, R.
    Montagnier, L.
    Epstein, S.
    Sasco, A. J.
    [J]. ENVIRONMENTAL RESEARCH, 2007, 105 (03) : 414 - 429
  • [10] Alcohol, tobacco and breast cancer -: collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease
    Beral, V
    Hamajima, N
    Hirose, K
    Rohan, T
    Calle, EE
    Heath, CW
    Coates, RJ
    Liff, JM
    Talamini, R
    Chantarakul, N
    Koetsawang, S
    Rachawat, D
    Morabia, A
    Schuman, L
    Stewart, W
    Szklo, M
    Bain, C
    Schofield, F
    Siskind, V
    Band, P
    Coldman, AJ
    Gallagher, RP
    Hislop, TG
    Yang, P
    Kolonel, LM
    Nomura, AMY
    Hu, J
    Johnson, KC
    Mao, Y
    De Sanjose, S
    Lee, N
    Marchbanks, P
    Ory, HW
    Peterson, HB
    Wilson, HG
    Wingo, PA
    Ebeling, K
    Kunde, D
    Nishan, P
    Hopper, JL
    Colditz, G
    Gajalakshmi, V
    Martin, N
    Pardthaisong, T
    Solpisornkosol, S
    Theetranont, C
    Boosiri, B
    Chutivongse, S
    Jimakorn, P
    Virutamasen, P
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (11) : 1234 - 1245